{"id":33978,"date":"2020-08-28T18:16:44","date_gmt":"2020-08-28T17:16:44","guid":{"rendered":"https:\/\/www.biotechpharmasummit.com\/?page_id=33978"},"modified":"2023-05-09T21:50:10","modified_gmt":"2023-05-09T20:50:10","slug":"daniel-grolz","status":"publish","type":"page","link":"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/daniel-grolz\/","title":{"rendered":"Daniel Gr\u00f6lz"},"content":{"rendered":"<div class=\"vgblk-rw-wrapper limit-wrapper\">\n\n\t<h2>Daniel Gr\u00f6lz<\/h2>\n<h4>Scientific Associate Director R&amp;D, Sample Technologies Department at QIAGEN<\/h4>\n\t<p>Dr. Daniel Gr\u00f6lz is a Scientific Associate Director of Research and Development at QIAGEN in Hilden, Germany. Dr. Groelz is the R&amp;D project manager who led an international team within PreAnalytiX GmbH to develop the PAXgene Tissue and the PAXgene Blood ccfDNA Systems. He was the leader for the evaluation of the PAXgene Tissue System within the European collaborative grant project, SPIDIA, and manages work packages in two other grant projects to evaluate the PAXgene Tissue and PAXgene Blood ccfDNA Systems for use in routine pathology workflows. He is the main inventor of the PAXgene Tissue System and inventor\/co-inventor of the PAXgene Blood ccfDNA stabilization chemistry.<\/p>\n<p>Prior to joining QIAGEN, Dr. Groelz worked for Autoimmun Diagnostika GmbH in Albstadt, Germany. Dr. Groelz received a Ph.D. in Biology from the University of Mainz with a concentration in Physiological Chemistry.<\/p>\n\t\t\t\t\t\t\t<img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Daniel_Gro\u0308lz_QIAGEN_1.jpg\" alt=\"Daniel_Gro\u0308lz_QIAGEN_1\" itemprop=\"image\" height=\"1224\" width=\"820\" title=\"Daniel_Gro\u0308lz_QIAGEN_1\" onerror=\"this.style.display='none'\"  sizes=\"auto, (max-width: 768px) 100vw, 100vw\" srcset=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Daniel_Gro\u0308lz_QIAGEN_1.jpg 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Daniel_Gro\u0308lz_QIAGEN_1-201x300.jpg 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Daniel_Gro\u0308lz_QIAGEN_1-686x1024.jpg 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Daniel_Gro\u0308lz_QIAGEN_1-768x1146.jpg 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Daniel_Gro\u0308lz_QIAGEN_1-630x940.jpg 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Daniel_Gro\u0308lz_QIAGEN_1-420x627.jpg 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Daniel_Gro\u0308lz_QIAGEN_1-315x470.jpg 315w\" \/>\t\t\t\t\t\t\t\n<h3>\n\tTitle: Circulating tumor DNA- preanalytical considerations, international specimen improvement requirements, standards, legislation, technologies\n\t<\/h3>\n<ul>\n<li>Need of specimen quality improvement to reduce diagnostic errors<\/li>\n<li>Pre-analytical factors that influence the outcome of ccfDNA analysis<\/li>\n<li>International initiatives and requirements to standardize pre-analytical workflows<\/li>\n<li>Liquid biopsy preservation and workflow solutions<\/li>\n<\/ul>\n\t<a href=\"https:\/\/sociopharma.com\/\" target=\"_blank\" role=\"button\" rel=\"noopener\">\n\t\t\t\t\tPresentation available only at SocioPharma.com\n\t<\/a>\n<h4>\n\t\t\t<a href=\"#\" title=\"On the Web\" target=\"_self\" rel=\"noopener\">\n\tOn the Web\n\t\t\t<\/a>\n\t<\/h4>\n\t<p><a href=\"https:\/\/www.qiagen.com\/\" target=\"_blank\" rel=\"noopener\">https:\/\/www.qiagen.com\/<\/a><\/p>\n<h4>\n\t\t\t<a href=\"#\" title=\"On LinkedIn\" target=\"_self\" rel=\"noopener\">\n\tOn LinkedIn\n\t\t\t<\/a>\n\t<\/h4>\n\t<p><a href=\"https:\/\/www.linkedin.com\/in\/daniel-groelz-0795a233\/\" target=\"_blank\" rel=\"noopener\">Visit profile<\/a><\/p>\n\n<\/div><!-- .vgblk-rw-wrapper -->","protected":false},"excerpt":{"rendered":"<p>Daniel Gr\u00f6lz Scientific Associate Director R&amp;D, Sample Technologies Department at QIAGEN Dr. Daniel Gr\u00f6lz is a Scientific Associate Director of Research and Development at QIAGEN in Hilden, Germany. Dr. Groelz is the R&amp;D project manager who led an international team within PreAnalytiX GmbH to develop the PAXgene Tissue and the PAXgene Blood ccfDNA Systems. He&#8230;<\/p>\n","protected":false},"author":1,"featured_media":33979,"parent":33918,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-33978","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Daniel Gr\u00f6lz &#8226; BioTech Pharma Summit<\/title>\n<meta name=\"description\" content=\"Dr. Daniel Gr\u00f6lz is a Scientific Associate Director of Research and Development at QIAGEN in Hilden, Germany.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/daniel-grolz\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Daniel Gr\u00f6lz &#8226; BioTech Pharma Summit\" \/>\n<meta property=\"og:description\" content=\"Dr. Daniel Gr\u00f6lz is a Scientific Associate Director of Research and Development at QIAGEN in Hilden, Germany.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/daniel-grolz\/\" \/>\n<meta property=\"og:site_name\" content=\"BioTech Pharma Summit\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/biotechpharmasummit\/\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-09T20:50:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Daniel_Gro\u0308lz_QIAGEN.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@biotechsummit\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/daniel-grolz\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/daniel-grolz\/\",\"name\":\"Daniel Gr\u00f6lz &#8226; BioTech Pharma Summit\",\"isPartOf\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/daniel-grolz\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/daniel-grolz\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Daniel_Gro\u0308lz_QIAGEN.jpg\",\"datePublished\":\"2020-08-28T17:16:44+00:00\",\"dateModified\":\"2023-05-09T20:50:10+00:00\",\"description\":\"Dr. Daniel Gr\u00f6lz is a Scientific Associate Director of Research and Development at QIAGEN in Hilden, Germany.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/daniel-grolz\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/daniel-grolz\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/daniel-grolz\/#primaryimage\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Daniel_Gro\u0308lz_QIAGEN.jpg\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Daniel_Gro\u0308lz_QIAGEN.jpg\",\"width\":900,\"height\":900},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/daniel-grolz\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.biotechpharmasummit.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Liquid Biopsy 2020 Speakers\",\"item\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Daniel Gr\u00f6lz\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"name\":\"BioTech Pharma Summit\",\"description\":\"The Tomorrow&#039;s healthcare congress\",\"publisher\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\",\"name\":\"EPM Group\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"width\":2000,\"height\":2000,\"caption\":\"EPM Group\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/biotechpharmasummit\/\",\"https:\/\/x.com\/biotechsummit\",\"https:\/\/www.instagram.com\/biotechpharmasummit\/\",\"https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Daniel Gr\u00f6lz &#8226; BioTech Pharma Summit","description":"Dr. Daniel Gr\u00f6lz is a Scientific Associate Director of Research and Development at QIAGEN in Hilden, Germany.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/daniel-grolz\/","og_locale":"en_US","og_type":"article","og_title":"Daniel Gr\u00f6lz &#8226; BioTech Pharma Summit","og_description":"Dr. Daniel Gr\u00f6lz is a Scientific Associate Director of Research and Development at QIAGEN in Hilden, Germany.","og_url":"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/daniel-grolz\/","og_site_name":"BioTech Pharma Summit","article_publisher":"https:\/\/www.facebook.com\/biotechpharmasummit\/","article_modified_time":"2023-05-09T20:50:10+00:00","og_image":[{"width":900,"height":900,"url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Daniel_Gro\u0308lz_QIAGEN.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@biotechsummit","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/daniel-grolz\/","url":"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/daniel-grolz\/","name":"Daniel Gr\u00f6lz &#8226; BioTech Pharma Summit","isPartOf":{"@id":"https:\/\/www.biotechpharmasummit.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/daniel-grolz\/#primaryimage"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/daniel-grolz\/#primaryimage"},"thumbnailUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Daniel_Gro\u0308lz_QIAGEN.jpg","datePublished":"2020-08-28T17:16:44+00:00","dateModified":"2023-05-09T20:50:10+00:00","description":"Dr. Daniel Gr\u00f6lz is a Scientific Associate Director of Research and Development at QIAGEN in Hilden, Germany.","breadcrumb":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/daniel-grolz\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/daniel-grolz\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/daniel-grolz\/#primaryimage","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Daniel_Gro\u0308lz_QIAGEN.jpg","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Daniel_Gro\u0308lz_QIAGEN.jpg","width":900,"height":900},{"@type":"BreadcrumbList","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/daniel-grolz\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.biotechpharmasummit.com\/"},{"@type":"ListItem","position":2,"name":"Liquid Biopsy 2020 Speakers","item":"https:\/\/www.biotechpharmasummit.com\/index.php\/liquid-biopsy-2020-speakers\/"},{"@type":"ListItem","position":3,"name":"Daniel Gr\u00f6lz"}]},{"@type":"WebSite","@id":"https:\/\/www.biotechpharmasummit.com\/#website","url":"https:\/\/www.biotechpharmasummit.com\/","name":"BioTech Pharma Summit","description":"The Tomorrow&#039;s healthcare congress","publisher":{"@id":"https:\/\/www.biotechpharmasummit.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.biotechpharmasummit.com\/#organization","name":"EPM Group","url":"https:\/\/www.biotechpharmasummit.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","width":2000,"height":2000,"caption":"EPM Group"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/biotechpharmasummit\/","https:\/\/x.com\/biotechsummit","https:\/\/www.instagram.com\/biotechpharmasummit\/","https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/33978","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/comments?post=33978"}],"version-history":[{"count":5,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/33978\/revisions"}],"predecessor-version":[{"id":38338,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/33978\/revisions\/38338"}],"up":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/33918"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media\/33979"}],"wp:attachment":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media?parent=33978"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}